New funding and advisory arm connects InsurTech startups with investors, corporate venture capital, and strategic partners to accelerate industry innovation.
Read More- CID-103 is a potential best-in-class, clinical stage anti-CD38 monoclonal antibody
- Safety profile observed in first four dose cohorts supports continued development
- No serious adverse events or dose-limiting toxicities have been reported
Read More
· Research focused on long-acting therapeutics based on Remedium's proprietary Prometheus™ platform
· Multiple targets for the treatment of Obesity and Type 2 Diabetes
Read More
Is the DEA the Epitome of Ineptitude?
"Why is the VA importing cannabis that U.S. companies have been ready to produce for years? If American cannabis is ‘too dangerous' for research, why is foreign cannabis treatment suddenly acceptable for our veterans?" asked Duane Boise, CEO of MMJ International Holdings.
Read More